HomeCompareLTGHF vs MRK

LTGHF vs MRK: Dividend Comparison 2026

LTGHF yields 24.39% · MRK yields 3.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $6.6K in total portfolio value· pulled ahead in Year 5
10 years
LTGHF
LTGHF
● Live price
24.39%
Share price
$0.68
Annual div
$0.17
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24.2K
Annual income
$2.93
Full LTGHF calculator →
MRK
Merck & Co. Inc.
● Live price
3.25%
Share price
$94.80
Annual div
$3.08
5Y div CAGR
8.2%
Payout ratio
42%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$950.29
Full MRK calculator →

Portfolio growth — LTGHF vs MRK

📍 MRK pulled ahead of the other in Year 5

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodLTGHFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, LTGHF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
LTGHF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LTGHF
Annual income on $10K today (after 15% tax)
$2,072.74/yr
After 10yr DRIP, annual income (after tax)
$2.49/yr
MRK
Annual income on $10K today (after 15% tax)
$276.16/yr
After 10yr DRIP, annual income (after tax)
$807.75/yr
At 15% tax rate, MRK beats the other by $805.26/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LTGHF + MRK for your $10,000?

LTGHF: 50%MRK: 50%
100% MRK50/50100% LTGHF
Portfolio after 10yr
$27.5K
Annual income
$476.61/yr
Blended yield
1.74%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

LTGHF
No analyst data
Altman Z
-126.7
Piotroski
6/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+35.6% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LTGHF buys
0
MRK buys
0
No recent congressional trades found for LTGHF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricLTGHFMRK
Forward yield24.39%3.25%
Annual dividend / share$0.17$3.08
Payout ratio50%42%
1-year div growth0%5.5%
5-year div CAGR-50%8.2%
Portfolio after 10y$24.2K$30.7K
Annual income after 10y$2.93$950.29
Total dividends collected$2.6K$6.1K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: LTGHF vs MRK ($10,000, DRIP)

YearLTGHF PortfolioLTGHF Income/yrMRK PortfolioMRK Income/yrGap
1$11,919$1,219.26$11,192$351.54+$727.00LTGHF
2$13,433$679.10$12,524$392.70+$909.00LTGHF
3$14,731$357.63$14,015$438.65+$716.00LTGHF
4$15,945$183.26$15,682$489.96+$263.00LTGHF
5← crossover$17,154$92.70$17,547$547.23$393.00MRK
6$18,401$46.60$19,632$611.16$1.2KMRK
7$19,713$23.36$21,963$682.53$2.3KMRK
8$21,104$11.69$24,571$762.18$3.5KMRK
9$22,587$5.85$27,486$851.08$4.9KMRK
10$24,171$2.93$30,745$950.29$6.6KMRK

LTGHF vs MRK: Complete Analysis 2026

LTGHFStock

Life Healthcare Group Holdings Limited, together with its subsidiaries, operates private hospitals in South Africa, Canada, the United Kingdom, rest of Europe, and Internationally. It operates through two segments, Hospitals and Complementary Services; and Healthcare Services. The company provides range of acute hospitals and complementary services; Life Esidimeni services, such as chronic mental healthcare, frail care rehabilitation, step-down care, correctional services, and primary healthcare and substance abuse recovery programs; and life employee health solutions, including on-site occupational and primary healthcare services and employee wellness programs. It also offers services in the areas of diagnostics, mental health, acute rehabilitation, renal dialysis, oncology, cardiology, neurology, orthopedic, pediatric, dermatology, ophthalmology, gynecology, and obstetric. In addition, the company provides diagnostic imaging services; magnetic resonance imaging and computerized tomography scanners; develops, manufactures, and distributes radiopharmaceuticals for use in positron emission tomography-computerized tomography (PET-CT) diagnostics. The company was formerly known as Afrox Healthcare Limited and changed its name to Life Healthcare Group Holdings Limited in January 2005. Life Healthcare Group Holdings Limited was founded in 1983 and is headquartered in Johannesburg, South Africa.

Full LTGHF Calculator →

MRKHealthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →
📬

Get this LTGHF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LTGHF vs SCHDLTGHF vs JEPILTGHF vs OLTGHF vs KOLTGHF vs MAINLTGHF vs JNJLTGHF vs ABBVLTGHF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.